SHIELD Joint Action project launched – official announcement
Every year, more than two million people in Europe develop cancer, and one in eight of these cancer cases are caused by an infection that could have been prevented (HPV, hepatitis B and C, HIV and TB). That is why the EU as part of Europe’s Beating Cancer Plan is now investing in preventing infections that can lead to cancer by making it easier to get vaccinated, tested and treated.
The new EU-wide project, SHIELD Joint Action, is funded with almost EUR 20 million by the EU. A total of 25 European countries are partners in the project which will be coordinated by Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, Denmark.
The SHIELD Joint Action will work to ensure that more people have access to HPV and hepatitis B vaccination and improve detection and testing for hepatitis B, hepatitis C, HPV, HIV, and TB.
For further details about the project, download the full press release here.
Source : SHIELD Joint Action
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.